Month: February 2023

The Ghana Health Service says a shortage of routine vaccines for children blamed for a measles outbreak that infected 120 will be resolved within weeks. Health officials said the shortage of vaccines against polio, hepatitis B, and measles was caused by the depreciation of Ghana’s currency, the cedi. The Pediatric Society of Ghana warned childhood diseases could quickly spread if the vaccines were not soon made available.

For months, nursing mothers have been complaining of shortage of vaccines meant for babies from birth to at least 18 months.

The situation became worse in February after major health facilities in 10 out of the 16 administrative regions of Ghana kept turning nursing mothers away due to erratic supply.

Vivian Helemi said her baby girl missed one of the key vaccinations last month and the situation has not changed after combing three health centers on Monday. Like other mothers, Helemi is worried the shortage of the essential vaccines for infants will pose a threat to her child.

“It has been frustrating moving from one hospital to another,” she told VOA. “I don’t know what could happen to my baby because she is yet to receive her second vaccination. I am confused because no one is telling me when the vaccines will be ready.”

Timely vaccination of children, according to UNICEF, is a proven method for saving lives from vaccine-preventable diseases. It can also help attain some targets like the U.N. Sustainable Development Goal 3, which aims to ensure healthy lives and promote well-being for all.

UNICEF’s Ghana office says on its website that the country has seen a significant fall in deaths from vaccine-preventable diseases. For example, since 2003, there has been no death caused by measles, while in 2011, Ghana was certified as having attained elimination status for maternal and neonatal tetanus.

Dr. Agyeiwaa Bonuedie, a member of the Pediatric Society of Ghana, said the government must act now in order not to erode the gains made so far.

“It’s the first time I am hearing of such widespread shortages. We do have shortages from time to time, however, those are in very limited circumstances. The problem this time is that it has gone over for several months. This should actually be a thing of the past. The government should be encouraged to do what we call ring-fenced funding such that budgetary allocations for vaccines are actually protected, no matter what other dire or pressing needs the country has, the children should be secured in that light,” said Bonuedie.

The director-general of the Ghana Health Service, Dr. Patrick Kuma-Aboagye, said the situation will change by the end of March.

“We have had some delays in procuring some of those vaccines for which polio, MR [Measles-Rubella], and BCG [bacille Calmette-Guerin] are in short supply. It was also because the ministry’s budget to procure them are in cedis, and at the time it was due for procurement, because of exchange differences it was very difficult to procure, so now we have done it… we hope that within the next three weeks we will address it,” he said.

Parliament has summoned the West African country’s health minister Kwaku Agyeman-Manu to discuss the vaccine shortage. The next few weeks are crucial for many children, especially those who live in inner cities and dense parts of urban areas and are exposed to vaccine-preventable diseases at an early age.

Source: Voice of America

Only a bold and ambitious U.N. treaty with sweeping reforms of the entire plastic life cycle can stem the world’s waste crisis, experts said Monday.

Even if measures thought to have the greatest potential for reducing plastic consumption are implemented, they would still fail to prevent a substantial rise in plastics production and use, they warned in a report.

A year ago, 175 nations agreed to end plastic pollution by crafting a binding U.N. treaty, which could come into being as soon as the end of 2024.

Among the key actions under negotiation are a global ban on single-use plastic items, a “polluter pays” scheme, and a tax on new plastic production.

But even with these policies there is a “considerable” possibility the treaty “will be too weak to bend the consumption curve downward”, the authors said in a statement.

On current trends, plastic use will nearly double from 2019 across G-20 countries by 2050, reaching 451 million tons each year, according to the report, jointly produced by Economist Impact and The Nippon Foundation.

In 1950, only two million tons of plastic were produced worldwide.

“The findings highlight the level of ambition and the sense of urgency needed at the negotiation table,” co-author Gillian Parker told AFP.

Not an impossible problem

The report modelled the three policy approaches — all under discussion at the U.N. talks — covering the entire life cycle of plastic, from production to disposal.

A global ban on unnecessary single-use plastics, including plastic sachets, cotton buds and balloon sticks, would by 2050 slow the growth in plastics consumption by only 14 percent.

So-called extended producer responsibility schemes, which put the onus on industry, would barely dent the projected increase in plastic use, reducing it from 451 to 433 million tons.

And even a substantial tax on “virgin” plastic resin, the raw material for making plastics, would only shave 10 percent off the baseline projection out to 2050.

Combined implementation of all three measures would still allow plastic consumption to grow by a quarter.

Even these inadequate measures face stiff headwinds: producers, retailers, industry bodies and consumer groups are likely to oppose some or all of them, according to the report.

“Industry has been very clear in saying they do not think taxes are productive,” said Parker. Manufacturers are even less enthusiastic about production cuts.

Recycling, the report showed, has not lived up to expectations, even if it remains part of the solution. It’s like “closing the door after the horses bolted”, said Parker.

It is more efficient to intervene at the beginning of the plastics pipeline than at the end, when we’re throwing everything away, she suggested.

Many countries lack the infrastructure to handle the scale of plastic waste generated and it remains cheaper to produce virgin plastic than recycle it.

Parker and her team, however, are still optimistic. “This is not an impossible problem,” she told AFP.

With the right binding and enforceable interventions and economic incentives, plastic pollution is “solvable”, she said.

Source: Voice of America

Tom Cruise was honored for his nearly three decades of work as a producer, and “ Everything Everywhere All at Once ” solidified its status as the frontrunner for the best picture Oscar by taking the top prize at Saturday night’s Producers Guild of America Awards.

“We love you! We love you!” another Oscar favorite and one of the film’s stars, Ke Huy Quan, shouted gleefully from the stage as Jonathan Wang and the other producers of the multiversal dramedy accepted the award for best theatrical motion picture.

The award has proven to be perhaps the best indicator for what will win the top honor at the Oscars, with four of the past five and 11 of the past 14 PGA winners going on to win best picture.

PGA wins by “ CODA ” last year and “ Nomadland ” in 2021 set each apart as frontrunners before winning best picture.

The strong possibility of a big night at Sunday’s Screen Actors Guild Awards could further mark “Everything Everywhere” as the film to beat at the March 12 Academy Awards.

Cruise the actor caused a stir inside and outside with his presence at the show at the Beverly Hilton in Beverly Hills, California, but his producing career beginning in 1996 with “Mission: Impossible” earned him the David O. Selznick Award at the PGAs, a life achievement honor previously bestowed on Steven Spielberg, Kevin Feige, Mary Parent and Brian Grazer.

“My whole life I wanted to make movies,” said Cruise, wearing a tuxedo with his hair grown out to the length he wore it in “Mission: Impossible 2.” “I wanted to travel the world, and have adventure.”

Cruise talked about making his film debut in 1981’s “Taps” at age 18 and how producer Stanley Jaffe let him in on every part of the process.

“I was certain this was something I wanted to do for the rest of my life,” he said.

Cruise thanked Jerry Bruckheimer, producer of the original 1986 “Top Gun” and his producing partner on last year’s “Top Gun: Maverick,” which also was nominated for the top PGA award and is up for the best picture Oscar.

“You opened the door for me,” Cruise told Bruckheimer. “You welcomed me in and I will be grateful forever.”

Since the first “Mission: Impossible,” Cruise has regularly been a producer on the films in which he has starred, including “Vanilla Sky,” “The Last Samurai,” “Jack Reacher” and the other five films in the “Mission: Impossible” franchise.

He paid tribute in his acceptance to many other mentors and partners including Spielberg and former Paramount CEO Sherry Lansing, who presented the award.

“You’ve all enabled me the adventurous life that I wanted,” he said.

Cruise gave a closing shout-out to “all the audiences, for whom I work first and foremost, thank you for letting me entertain you.”

Other movies honored by the PGA included “Navalny,” which won for best documentary feature, “Guillermo del Toro’s Pinocchio,” which took best animated film, and “Till,” which won the Stanley Kramer Award honoring a production or producer that illuminates and raises public awareness of important social issues.

In the PGA’s television categories, “The Bear” won for best comedy, “The White Lotus” won for best drama, “Lizzo’s Watch Out For The Big Grrrls” won for best reality or competition series, “Stanley Tucci: Searching for Italy” won for non-fiction series, “The Dropout” won best limited series and “Weird: The Al Yankovic Story” won best TV movie.

Mindy Kaling received the Norman Lear Achievement Award in Television for her work producing shows including “The Mindy Project,” “The Sex Lives of College Girls,” “Never Have I Ever,” “Velma” and “The Office.”

“I’m a child of immigrants and that unexpectedly became my secret weapon,” Kaling said.

B.J. Novak, her former “Office” co-writer and co-star, presented Kaling with the award, saying she “cared about characters other people hadn’t cared about enough to put on TV, and they cared about things that other people on TV hadn’t cared about.”

Source: Voice of America

Last year, the top winners at the Screen Actors Guild Awards all corresponded exactly with the Academy Awards winners. Will Sunday’s SAGs offer the same preview?

The 29th annual Screen Actors Guild Awards will begin at 8 p.m. EST Sunday and be streamed live on Netflix’s YouTube page. After the awards, presented by the film and television acting guild SAG-AFRTA, lost their broadcast home at TNT/TBS, Netflix signed on to stream the ceremony. Though future editions will be streamed live directly on Netflix, this year’s show, at Fairmont Century Plaza in Los Angeles, will be on the streaming service’s YouTube page and its social media channels.

“Everything Everywhere All at Once” and “The Banshees of Inisherin” come in with a co-leading five nominations. Each film is up for the Guild’s top award, best ensemble, along with “Babylon,” “The Fabelmans” and “Women Talking.”

The SAG Awards are considered one of the most reliable Oscar bellwethers. Actors make up the biggest percentage of the film academy, so their choices have the largest sway. Last year, “CODA” triumphed at SAG before winning best picture at the Oscars, while Ariana DeBose, Will Smith, Jessica Chastain and Troy Kotsur all won both a SAG Award and an Academy Award.

With both supporting categories seemingly sown up by Angela Bassett (“Black Panther: Wakanda Forever”) and Ke Huy Quan (“Everything Everywhere All at Once”), Sunday’s SAG Award could offer the most clarity in the lead acting awards.

Best actress could go to either Michelle Yeoh (“Everything Everywhere All at Once”) or Cate Blanchett (“Tár”). While Andrea Riseborough’s much-debated campaign led to an Academy Awards nomination, some of the most notable Oscar snubs are up for best actress. Though nominated by the actors’ guild, Danielle Deadwyler (“Till”) and Viola Davis (“The Woman King”) were overlooked by the academy, prompting some to decry racial bias in Hollywood. Ana de Armas (“Blonde”) is also nominated.

In the best actor category, Austin Butler (“Elvis”), Brendan Fraser (“The Whale”) and Colin Farrell (“The Banshees of Inisherin”) all are considered contenders with a realistic shot of winning. The Guild also nominated Adam Sandler (“Hustle”) and Bill Nighy (“Living”).

On the TV side, nominated for best ensemble in a drama series are: “Better Call Saul,” “The Crown,” “Ozark,” “Severance” and “The White Lotus.” Up for best comedy series ensemble are the casts of “Abbott Elementary,” “Barry,” “The Bear,” “Hacks” and “Only Murders in the Building.”

Presenters on Sunday include Zendaya (who scored her first SAG nomination for her leading performance in “Euphoria,” Aubrey Plaza, Jenna Ortega, Adam Scott, Chastain and Jeff Bridges. Sally Field is to receive the SAG lifetime achievement award, an honor to be presented to her by Andrew Garfield.

Source: Voice of America

The Biden administration is preparing for a worst-case scenario if a conservative federal judge rules in favor of a lawsuit seeking to restrict access to one of the two drugs typically used to induce a medicated abortion.

Two drugs, mifepristone and misoprostol, can be taken by women at home and are used for just over half of U.S. abortions. But that could be quickly changed by a lawsuit filed by an anti-abortion group in Texas that claims the Food and Drug Administration wrongly approved mifepristone for use more than 23 years ago.

The case is before a federal judge appointed by former President Donald Trump. A ruling in favor of the abortion opponents could immediately shut down the sale of the drug, but women would still have access to medicated abortions with a regimen of misoprostol.

Vice President Kamala Harris promised on Friday that the White House would push back on efforts to ban the drug, as she gathered a group of nearly a dozen doctors and abortion rights advocates to discuss a plan for responding to the looming threat to access to medical abortions.

“There are now partisan and political attacks attempting to question the legitimacy of a group of scientists and doctors who have studied the significance of this drug,” Harris said. “There is now an attempt by politicians to remove it from the ability of doctors to prescribe and the ability of people to receive.”

The lawsuit against mifepristone was filed by the Alliance for Defending Freedom, which was also involved in the Mississippi case that led to Roe v. Wade being overturned. It’s the latest fallout in the struggle over reproductive care that the Democratic administration must grapple with since the Supreme Court overturned the constitutional right to an abortion last year.

Harris did not publicly lay out how the administration plans to respond if a ruling that halts the sale of the drug nationwide comes down on Friday.

‘Medication abortion is not going away’

Health and Human Services Secretary Xavier Becerra, meanwhile, was in California on Friday to meet leaders from Planned Parenthood to talk about access to the abortion drugs.

Dr. Kristyn Brandi said she told the vice president on Friday that the ruling could trigger widespread confusion over the accessibility of medicated abortion in the U.S. Brandi, who is chair of the Physicians for Reproductive Health, said she already fields calls at her New Jersey clinic from women asking if medicated abortion is legal in the state.

“It’s a really important thing to communicate with people: medication abortion is not going away,” Brandi said.

She added that Harris expressed support for immediately challenging the ruling if it shuts down access to mifepristone.

Clinics and telehealth providers have been preparing for a ruling that shuts down access to mifepristone, ordering more doses of misoprostol so they can offer medication abortions with just that one drug. They will have to change the way they counsel patients, telling them that misoprostol-only abortions are slightly less effective and sometimes more painful than abortions done with both drugs.

Abortions using both drugs “can be as effective as 98% or more,” while misoprostol-only abortions are up to about 95% effective, Melissa Grant, chief operating officer of the Carafem abortion clinic, told The Associated Press.

Mifepristone dilates the cervix and blocks the action of the hormone progesterone, which enables a pregnancy to continue. Misoprostol causes contractions that empty the uterus. Typically, mifepristone is taken by mouth first, followed by misoprostol a day or two later.

Studies show medication abortions are safe and effective, though with a slightly lower success rate than ones done by procedure in a clinic.

Another lawsuit filed

With the Texas decision pending, a dozen Democratic-controlled states filed their own lawsuit in federal court against the FDA on Thursday in Washington. The lawsuit seeks to make it easier for woman to access the drug and alleges that several FDA requirements for prescribing and dispensing it are “burdensome, harmful and unnecessary.”

When the FDA approved mifepristone in 2000 it placed several safety restrictions on its use, including limiting dispensing to specialty clinics and requiring women to pick up the drug in person. The Biden administration had sought to expand access to medicated abortions in light of the Supreme Court’s ruling, with an FDA announcement this year that broadened the pill’s access through retail and mail-order pharmacies.

But several limitations remain, such as one that doctors must be specially certified to prescribe the drug.

Several medical groups have long opposed those requirements, pointing to the low rate of side effects seen with mifepristone compared with other medications that don’t carry any certification requirements.

Source: Voice Of America

Uber Technologies Inc. said on Friday plans by the local government in India’s Delhi city to only allow electric vehicles to function as bike taxis would risk “finishing off the sector” and impact the mobility needs of millions.

Delhi’s plans, part of a new policy to regulate vehicles used by ride-hailing companies like Uber and rival Ola, are being finalized and will be rolled out soon, the Economic Times reported earlier this week.

Reuters could not immediately confirm those plans.

If implemented, this would mark an aggressive step towards the country’s ambitions to ramp up the transition to vehicles that run on clean energy to reduce oil imports and curb pollution.

Uber, in a blogpost, said any such move would put at risk the livelihood of over 100,000 drivers in the city.

“Steep and infeasible EV mandates risk finishing off the sector as we know it. The impact of such a decision on the livelihoods and mobility needs of millions of Delhiites is clear,” San Francisco-headquartered Uber said, urging the government to initiate industry dialog.

Uber has set a 2040 target for 100% of its rides to be in zero-emission vehicles, public transport or with micro-mobility, including in India.

Earlier this month, Uber announced plans to introduce 25,000 EVs over three years in India. Electric cars will however still be a fraction of Uber’s current overall active fleet of 300,000 vehicles in India.

On Sunday, the Delhi government in newspaper ads said digital platforms offering two-wheeler bike taxi rides should not do so as it violates certain existing transport rules.

Uber, which offers bike rides in Delhi and many other states in India, did not respond to a Reuters request for a comment on the advertisement.

Source: Voice Of America